Cargando…

Ibrutinib: Implications for Use in the Treatment of Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia

Detalles Bibliográficos
Autores principales: McNally, Gretchen Anne, Long, Jennifer M., Brophy, Lynne R., Badillo, Maria R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803460/
https://www.ncbi.nlm.nih.gov/pubmed/27069735
_version_ 1782422875622342656
author McNally, Gretchen Anne
Long, Jennifer M.
Brophy, Lynne R.
Badillo, Maria R.
author_facet McNally, Gretchen Anne
Long, Jennifer M.
Brophy, Lynne R.
Badillo, Maria R.
author_sort McNally, Gretchen Anne
collection PubMed
description
format Online
Article
Text
id pubmed-4803460
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Harborside Press
record_format MEDLINE/PubMed
spelling pubmed-48034602016-04-11 Ibrutinib: Implications for Use in the Treatment of Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia McNally, Gretchen Anne Long, Jennifer M. Brophy, Lynne R. Badillo, Maria R. J Adv Pract Oncol Review Article Harborside Press 2015 2015-09-01 /pmc/articles/PMC4803460/ /pubmed/27069735 Text en Copyright © 2015, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
spellingShingle Review Article
McNally, Gretchen Anne
Long, Jennifer M.
Brophy, Lynne R.
Badillo, Maria R.
Ibrutinib: Implications for Use in the Treatment of Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
title Ibrutinib: Implications for Use in the Treatment of Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
title_full Ibrutinib: Implications for Use in the Treatment of Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
title_fullStr Ibrutinib: Implications for Use in the Treatment of Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
title_full_unstemmed Ibrutinib: Implications for Use in the Treatment of Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
title_short Ibrutinib: Implications for Use in the Treatment of Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
title_sort ibrutinib: implications for use in the treatment of mantle cell lymphoma and chronic lymphocytic leukemia
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803460/
https://www.ncbi.nlm.nih.gov/pubmed/27069735
work_keys_str_mv AT mcnallygretchenanne ibrutinibimplicationsforuseinthetreatmentofmantlecelllymphomaandchroniclymphocyticleukemia
AT longjenniferm ibrutinibimplicationsforuseinthetreatmentofmantlecelllymphomaandchroniclymphocyticleukemia
AT brophylynner ibrutinibimplicationsforuseinthetreatmentofmantlecelllymphomaandchroniclymphocyticleukemia
AT badillomariar ibrutinibimplicationsforuseinthetreatmentofmantlecelllymphomaandchroniclymphocyticleukemia